Foamix to Present Corporate Overview at the Barclays Global Healthcare Conference

Wednesday, March 9, 2016 5:00 AM UTC

REHOVOT, Israel and BRIDGEWATER, N.J., March 09, 2016 -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announced today that David Domzalski, President, will provide a corporate overview and business update at the Barclays Global Healthcare Conference, taking place in Miami Beach, Florida, March 15-17, 2016.

	*Presentation Details:*
	Title:	Barclays Global Healthcare Conference
	Date:	Wednesday, March 16
	Time:	10:15am Eastern Time
	Location:	Loews Miami Beach Hotel, Miami Beach, Florida
	Webcast:	https://cc.talkpoint.com/barc002/031516a_ae/?entity=51_1HE71L7

About Foamix Pharmaceuticals Ltd.
Foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX102 for the treatment of impetigo, FMX 103 for the treatment of rosacea, and FDX104, our doxycycline foam for the management of acne-like rash, induced by EGFRI anticancer drugs.

In addition, we have development and license agreements relating to our technology with various pharmaceutical companies including Bayer HealthCare, Merz, Allergan and Prestium. For more information, please visit www.foamixpharma.com.

Contact:			
Dorit Hayon, BD		
Foamix Pharmaceuticals Ltd.	
+972-8-9316233		
[email protected]	

US Investor Relations
Michael Rice
LifeSci Advisors, LLC
646-597-6979
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Foamix to Present Corporate Overview at the Barclays Global Healthcare Conference

Editor's Picks

Welcome to EconoTimes